13.3 C
New York
Saturday, November 7, 2026
- Advertisement -spot_img

TAG

health

Measles outbreak in Pennsylvania Amish country grows

Pennsylvania has recorded over 1,350 measles cases this year, with Lancaster County at the centre, as Plain families show new openness to vaccination.

Mitapivat sickle cell decision moved to February 2027

The FDA extended its review of Agios mitapivat for sickle cell disease to 1 February 2027 after a safety plan response was classed as a major amendment.

Tractor Wheels toddler bars recalled after choking reports

The FDA warned consumers not to buy or serve Tractor Wheels toddler bars after toddlers suffered complete airway obstruction, and a recall followed.

Botanical products need strict FDA standards, AMA says

The AMA urged the FDA to hold botanical products to strict safety and efficacy standards, warning that unproven claims put consumers at risk now.

Voceryq wins FDA approval for rare airway disease

The FDA approved Voceryq, a DNA immunotherapy that aims to reduce repeat surgery for adults with recurrent respiratory papillomatosis on 30 October.

AIIMS shelter for patients inspected by Nadda

Health Minister J.P. Nadda inspected a new 897-capacity AIIMS shelter for patients in Delhi and reviewed cleanliness under Special Campaign 6.

Tobacco-free youth campaign takes fight to colleges

India launched Tobacco-Free Youth Campaign 4.0 on 28 October 2026, a 60-day drive that moves the anti-tobacco push into universities and colleges.

Healthcare roadmap for 2047 sets out lower costs

Minister Anupriya Patel set out India's healthcare roadmap for 2047 at the Health Summit, citing wider Ayushman cover and falling patient costs.

Medicine import rule bars drugs with under a year left

India now bars medicine imports with under one year of shelf life left, with a 60 per cent allowance for biological drugs and radiopharmaceuticals.

TB patent rejected for drug-resistant treatment in India

India rejected a TB patent for the BPaL drug-resistant tuberculosis regimen, clearing a path for generic makers after patient groups opposed the claim.

Latest news

- Advertisement -spot_img